文献速递免疫规划传染病防控与疫情报告

埃塞俄比亚奥罗米亚地区麻疹流行病学与疫苗接种覆盖率:2011-2018年监测证据

Measles epidemiology and vaccination coverage in Oromia Region, Ethiopia: Evidence from surveillance, 2011-2018.
PubMed 文献 · Vaccine · 2021-06-16

该研究基于2011-2018年监测数据,分析埃塞俄比亚奥罗米亚地区麻疹感染与疫苗接种分布。各区域监测估计的MCV覆盖率均显著低于WHO推荐的90%群体免疫阈值,而行政报告覆盖率却持续高于90%,部分解释了高行政覆盖率下麻疹持续传播和暴发的矛盾。

要点

  • 1-4岁儿童和未接种MCV者为最受影响群体。
  • 监测估计MCV覆盖率显著低于WHO推荐的90%阈值。
  • 行政报告覆盖率持续高于90%,与监测估计存在明显不匹配。

核心结论

  • 奥罗米亚地区监测估计的MCV覆盖率远低于推荐的群体免疫阈值,部分解释了高行政覆盖率下麻疹持续传播和暴发的明显不匹配。

研究设计与样本

  • 基于2011-2018年监测数据的分析,依据WHO和埃塞俄比亚麻疹病例分类指南将病例分为实验室确诊、临床兼容和流行病学关联。
  • 利用报告的麻疹疫苗效力和监测数据中至少接种过一剂麻疹疫苗的病例比例,推导麻疹疫苗接种覆盖率估计,并计算地区麻疹有效再生数(Re)。

主要发现

  • 麻疹传播持续且强度高,在各区域间分布不均。
  • 1-4岁儿童和未接种MCV个体是最受影响群体。
  • 所有区域中,监测估计的婴儿和五岁以下儿童平均MCV覆盖率均显著低于WHO推荐的90%最低群体免疫阈值。
  • 在此疫苗接种覆盖率水平下,一个感染病例可传播给超过四个人。

关键数值与推荐

  • WHO推荐的MCV覆盖率最低群体免疫阈值为90%。
  • 监测估计的MCV覆盖率在所有区域均显著低于90%阈值。
  • 同期行政覆盖率报告持续高于90%。

临床怎么用

  • 奥罗米亚地区卫生局应与关键利益相关方合作,努力提高MCV有效覆盖率至少至90%。
  • 需扩大MCV多剂次接种,并利用监测数据证据配合适当的地理和年龄靶向。
  • 需要立即采取规划行动以提高麻疹监测质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite a reported high coverage of measles-containing vaccine (MCV), low-income countries including, Ethiopia, have sustained high measles transmission with frequent outbreaks. We investigated the distribution of measles infection and vaccination in Oromia Regional State, Ethiopia. According to the World Health Organization (WHO) and the Ethiopian measles case classification guidelines, measles cases were classified as laboratory-confirmed, clinically compatible, and epidemiologically linked. We derived measles vaccination coverage estimates using reported measles vaccine efficacy and, the proportion of measles cases vaccinated with measles vaccine at least once from the surveillance data. We calculated measles effective reproduction number (Re) in the region. Almost twenty-five thousand measles cases were reported through the surveillance system, with more than 50% of the suspected and confirmed measles cases reported in 2015. Measles had sustained and high transmission rate with uneven distribution among the zones. Children between 1 and 4 years of age and MCV unvaccinated individuals were the most affected groups. In all the zones, the average surveillance-estimated MCV coverage among both infants and under-five children was significantly lower than the WHO recommended minimum 90% threshold herd-immunity. With this level of vaccination coverage, an infected case can transmit to more than four individuals. Nevertheless, the administrative coverage reports for the concurrent period were consistently above 90%. The estimated MCV coverage across the Oromia region was well below the recommended herd-immunity threshold. It partly explains the apparent mismatch of sustained measles transmission and outbreaks despite the very high administrative coverage estimates. Oromia regional health bureau, in collaboration with key stakeholders, should make a concerted effort to increase the effective-coverage of MCV to at least 90%. Additionally, multiple-dose MCV has to be scaled-up and accompanied with appropriate geographic and age targeting using evidence from surveillance data. Immediate programmatic action is needed to improve the quality of measles surveillance.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Yitbarek K, Tilahun T, Debela T, et al. Measles epidemiology and vaccination coverage in Oromia Region, Ethiopia: Evidence from surveillance, 2011-2018. Vaccine. 2021. PMID: 34147294. doi:10.1016/j.vaccine.2021.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。